Ashman, L, Duggan, L (2008) Interventions for learning disabled sex offenders. Cochrane Database of Systematic Review, 1: CD003682 (doi:10.1002/14651858.CD003682.pub2).
Bancroft, J, Tennent, G, Loucas, K, et al (1974) The control of deviant sexual behaviour by drugs. 1. Behavioural changes following oestrogens and anti-androgens. British Journal of Psychiatry, 125: 310–5.
Bradford, JMW, Pawlak, A (1993) Effects of cyproterone acetate on sexual arousal patterns of paedophiles. Archives of Sexual Behavior, 22: 629–41.
Briken, P, Kafka, MP (2007) Pharmacological treatment for paraphilic patients and sexual offenders. Current Opinion in Psychiatry, 20: 609–13.
Briken, P, Müller, JL, Berner, W, et al (2017) Vom Scheitern einer Studie in Maßregelvollzugskrankenhäusern: Klinische Prüfung zum additiven Effekt von Triptorelin auf die Wirksamkeit von Psychotherapie [Failure of a study in forensic psychiatric hospitals: clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy]. Der Nervenarzt, 88: 480–5.
Cooper, AJ (1981) A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22: 458–65.
Dennis, J, Huband, N, Khan, O, et al (2012) Psychological interventions for adults who have sexually offended or are at risk of offending. Cochrane Database of Systematic Reviews, 12: CD007507 (doi: 10.1002/14651858.CD007507.pub2).
Duggan, CF, Hollin, CR, Huband, N, et al (2013) A comparison of mentally disordered male offenders with and without a sexual offence: their characteristics and outcome. Sex Offender Treatment, 8: 1–8.
Eastman, N, Adshead, G, Fox, S, et al (2012) Forensic Psychiatry. Oxford University Press.
Fazal, S, Grann, M (2006) The population impact of severe mental illness on violent crime. American Journal of Psychiatry, 163: 1397–403.
Firestone, P, Bradford, JM, Greenberg, DM, et al (2000) The relationship of deviant sexual arousal and psychopathy in incest offenders, extrafamilial child molesters, and rapists. Journal of the American Academy of Psychiatry and Law, 28: 303–8.
Hanson, RK, Bussiere, MT (1998) Predicting relapse: a meta-analysis of sexual offender recidivism studies. Journal of Consulting and Clinical Psychology, 66: 348–62.
Hucker, S, Langevin, R, Bain, J (1988) A double blind trial of sex drive reducing medication in paedophiles. Sexual Abuse: A Journal of Research and Treatment, 1: 227–42.
Khan, O, Ferriter, M, Huband, N, et al (2015) Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database of Systematic Reviews, 2: CD007989 (doi: 10.1002/14651858.CD007989.pub2).
Langevin, R, Paitich, D, Hucker, S, et al (1979) The effect of assertiveness training, Provera and sex of therapist in the treatment of genital exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry, 10: 275–82.
McConaghy, N, Blaszczynski, A, Kidson, W (1988) Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone. Acta Psychiatrica Scandinavica, 77: 199–206.
McEvoy, G (ed) (2017) AHFS Drug Information 2017. American Society of Health Information Pharmacists.
Prentky, RA, Lee, AFS, Knight, RA, et al (1997) Recidivism rates among child molesters and rapists: a methodological analysis. Law and Human Behavior, 21: 635–59.
Rösler, A, Witzum, E (1998) Treatment of men with paraphilia with a long-acting gonadotropin-releasing hormone. New England Journal of Medicine, 338: 416–22.
Taylor, PJ, Leese, M, Williams, D, et al (1998) Mental disorder and violence: a special (high security) hospital study. British Journal of Psychiatry, 172: 218–26.
Tennent, G, Bancroft, J, Cass, J (1974) The control of deviant sexual behaviour by drugs: a double-blind controlled study of benperidol, chlorpromazine and placebo. Archives of Sexual Behavior, 3: 261–71.
Turner, D, Basdekis-Jozsa, R, Briken, P (2013) Prescription of testosterone lowering medication for sex offender treatment in German forensic psychiatric institutions. Journal of Sexual Medicine, 10: 570–8.